12/22/2022
On behalf of the team at the California Institute for Regenerative Medicine, we wish you a safe and happy holiday!
Thank you to the people of California and our wonderful community for making 2022 a successful year.
California Institute for Regenerative Medicine
- Home
- United States
- Oakland, CA
- California Institute for Regenerative Medicine
CIRM is California's Stem Cell Agency.
CIRM accelerates world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. Our mission is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world.
Operating as usual
12/20/2022
CIRM Funds Clinical Trial to Make Cancer Therapy Safer, Less Toxic
“If successful, this approach can overcome hurdles to the success of chemotherapy and blood stem cell transplantation for the treatment of advanced blood cancer,” says Dr. Maria T. Millan, President and CEO of CIRM.
Blood stem cell transplantation following high dose chemotherapy is standard of care and potentially curative for aggressive forms of lymphoma. However, this treatment regimen is limited by severe …
12/16/2022
In Memory of Kevin McCormack
CIRM lost its voice this weekend.
Sunday evening, our beloved Director of Patient Advocacy and frequent face and voice of the Institute, Kevin McCormack, passed away unexpectedly, leaving an unfillable void in our hearts.
CIRM lost its voice this weekend. Sunday evening, our beloved Director of Patient Advocacy and frequent face and voice of the Institute, Kevin McCormack, passed away unexpectedly,…
12/07/2022
High school SPARK intern presents stem cell research to academic audience
During the CIRM SPARK summer internship, the high school student joined a lab at Sanford Burnham Prebys to study Duchenne Muscular Dystrophy (DMD) and how stem cells can be used to provide treatment.
Earlier this year, CIRM welcomed many energetic and enthusiastic high school students at the 2022 SPARK Program annual conference in Oakland. The SPARK program is one of the California Institute fo…
12/01/2022
Tratando malformaciones congénitas antes del nacimiento
El bebé Tobi recibió un tratamiento de células madre, financiado por el CIRM, mientras aún estaba en el útero.
“Cuando lo abrazamos por primera vez dijimos, ‘No puedo creer que hayamos hecho esto. Lo logramos. Lo hicimos sin saber si funcionaría’.”
El bebé, Tobi, que recibió un tratamiento de células madre financiado por el CIRM, mientras aún estaba en el útero, y sus padres Michelle y Jeff. To read this blog in English, click here. Michelle …
11/30/2022
Neurona Therapeutics Update: First two patients who received treatment experienced significantly less seizures
Both patients entered the study with a history of significant monthly seizures that were not controlled by anti-seizure medications.
So far, they have both seen encouraging signs of reduced seizures which suggest that a single dose of NRTX-1001 may have a long-lasting ability to suppress seizures.
Nearly 3.5 million Americans suffer from some form of epilepsy. It can affect people in different ways from stiff muscles or staring spells, to violent shaking and loss of consciousness. …
11/23/2022
Reasons to be thankful this Thanksgiving: creative nerds
🎶 When the working day is done oh nerds just wanna have funds. 🎶
We at the California Institute for Regenerative Medicine have a lot to be thankful for this Thanksgiving. We get to work with some extraordinary colleagues, we get to know some remarkable patient a…
11/21/2022
Pioneering a new approach to HIV/AIDS
Caring Cross announced recently that they have dosed the first patient in the trial testing their anti-HIV duoCAR-T cell therapy.
The goal of this one-time therapy is to act as a long-term control of HIV with patients no longer needing to take anti-HIV medications. If it is successful it would be, in effect, a form of functional HIV cure.
Dr. Steven Deeks. Photo courtesy UCSF I’ve always been impressed by the willingness of individuals to step forward and volunteer for a clinical trial. Even more so when they are the first person ev…
11/18/2022
Study could pave the way in reducing decline in muscle strength as people age
“We are hopeful that it might one day be possible to inject an antibody at specific sites in the body to regenerate muscle in older people or to counteract functional problems due to disease or surgery.”
A study by Stanford Medicine researchers in older mice may lead to treatments that help seniors regain muscle strength lost to aging. Muscle stem cells—which are activated in response to muscle inj…
11/14/2022
Sweet 16 and counting for stem cell clinical trial
There’s more encouraging news from a CIRM-funded clinical trial for severe combined immunodeficiency (SCID) with Jasper Therapeutics.
They have announced that they have tested their approach in 16 patients, with encouraging results and no serious adverse events.
Dr. Judy Shizuru: Photo courtesy Jasper Therapeutics Over the years the California Institute for Regenerative Medicine (CIRM) has invested a lot in helping children born with severe combined immuno…
11/08/2022
Patient Advocacy is its own reward
The California Institute for Regenerative Medicine (CIRM) has been named as a finalist for the Patient Advocacy Award (non-profit category) as part of the Phacilitate Advanced Therapies Awards.
It’s always nice to be told you are doing a good job. It’s even nicer when it’s unexpected. That’s certainly the case when we, the Communications Team at the California Institute for Regenerative M…
11/02/2022
The doctor who fights vision loss and wildfires
Dr. Dennis Clegg has lots of titles and honors but what makes him most interesting is the progress he is helping drive in finding cures for macular degeneration, one of the leading causes of vision loss in the world.
In this podcast Dennis talks about how a small patch they have developed is showing real promise in restoring vision.
Dennis Clegg, UC Santa Barbara researcher Doctor Dennis Clegg, a researcher and scientist at UC Santa Barbara, is fascinated by the eye. He thinks it’s one of the most beautiful objects in na…
10/27/2022
Developing a natural killer for cancer
Dr. Lili Yang is working on developing a stem cell-derived Natural Killer cell that can attack cancer.
She is doing it in a way that she hopes will make the therapy more effective, cheaper and widely available to everyone who needs it.
Lili Yang UCLA Broad Stem Cell Research Center: Photo courtesy Reed Hutchinson PhotoGraphics When Lili Yang was studying for her PhD she approached her mentor, the Nobel Laureate Dr. David Baltimor…
10/25/2022
Congratulations to Senator Art Torres (Ret.), the Vice Chair of the CIRM Board, who received a Dolores Huerta Lifetime Achievement Award this month!
During the ceremony, Dolores Huerta sent a video greeting from Texas (where she lives) and San Francisco Mayor London Breed presented him with a Certificate of Honor.
Mayor Breed praised Art for supporting immigrant communities, uplifting Latino residents, and for his advocacy and passion to secure critical funding for stem cell research in California.
We are thrilled to have Senator Art Torres (Ret.) serve on our Board and congratulate him for this amazing achievement!
Read more: https://bit.ly/3TUUbDv
10/17/2022
California researchers developing vaccine to curb the spread of Zika virus
To date, no vaccines or other treatments have been approved for Zika virus.
Zika is caused by a virus that is mainly transmitted by infected female Aedes aegypti mosquitoes but also through sexual in*******se. People infected by Zika virus usually have mild symptoms that n…
10/14/2022
Oregon baby is the second person to get a brand-new kind of fetal surgery to treat spina bifida
More promising news from the CIRM-funded stem cell clinical trial at UC Davis Health treating spina bifida.
The three babies from the trial that have been born so far will be monitored by the research team until 30 months of age to fully assess the procedure’s safety and effectiveness.
He was diagnosed with spina bifida while still in the womb, but thanks to this procedure he was born happy and healthy.
10/13/2022
Apply by Nov. 8th for CIRM Discovery stage funding!
CIRM’s goal is that the outcomes of the projects derived from this opportunity will ultimately create new avenues and provide a rigorous foundation for translational and clinical development work.
The California Institute for Regenerative Medicine (CIRM) is pleased to announce a new opportunity within our current funding cycle for Discovery stage programs: the DISC0 …
10/07/2022
World’s first stem cell treatment for spina bifida delivered during fetal surgery
The first phase of the clinical trial is funded by a $9 million state grant from the California Institute for Regenerative Medicine (CIRM).
Three babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
10/06/2022
Chemistry Nobel Prize winner Carolyn Bertozzi had a hand in early stem cell research
CIRM congratulates Carolyn Bertozzi for winning the Nobel Prize in Chemistry!
Bertozzi helped jump-start human embryonic stem cell (hESC) research in California and had a hand in early CIRM-funded stem cell research.
Carolyn Bertozzi. Image credit: Andrew Brodhead The 2022 Nobel Prize in Chemistry has been awarded to Carolyn R. Bertozzi of Stanford University, Morten Meldal of the University of Copenhagen, and …
09/26/2022
So far, some encouraging news for stem cell clinical trial treating epilepsy
Neurona Therapeutics is testing a new therapy for a drug-resistant form of epilepsy and has released some encouraging early findings: the first patient treated went from having more than 30 seizures a month to just four seizures over a three-month period.
Neurona Therapeutics is testing a new therapy for a drug-resistant form of epilepsy and has just released some encouraging early findings. The first patient treated went from having more than 30 se…
09/22/2022
The second Wednesday in October is . It’s a day when we mark the progress being made in regenerative medicine and the ways that it has changed and saved lives..
Join us on Wednesday, October 12th as we highlight the California Institute for Regenerative Medicine's achievements since we were created by the voters of California in 2004. We will also look to the future to explore how we can best further our mission.
Save your spot: bit.ly/StemCellAwarenessDay
09/19/2022
A pioneering couple uproot their lives to help their baby
When Michelle and Jeff learned they were expecting a baby, they were elated.
Then an ultrasound exam at 20 weeks into the pregnancy showed the fetus had spina bifida, a birth defect that occurs when the spine and spinal cord don’t form properly.
The couple were referred to UC Davis where Dr. Diana Farmer and Dr. Aijun Wang were running a clinical trial—funded by CIRM—using stem cells, taken from a donor placenta.
Read their story on our blog .
Our 2021-22 Annual Report is now online. It’s filled with information about the work we have done over the last year (we are on a fiscal calendar year from July 1 – June 30), the people…
09/14/2022
A newfound passion for stem cell research
“I’ve always felt that stem cell research feels like a treasure hunt looking for cures and treatments, so the more of us that are partaking in the treasure hunt, the quicker we can find new treatments and provide solutions for patients.”
All her life, Madison Waterlander knew that she wanted to be a part of the medical field. But soon after graduating from the University of Hawaii with her undergraduate degree, the COVID-19 pa…
09/12/2022
The race to cure sickle cell disease
The California Institute for Regenerative Medicine (CIRM) has invested almost $60 million in 14 projects, including five clinical trials targeting .
We've also partnered with the National Heart, Lung, and Blood Institute (NHLBI) in their Cure Sickle Cell Initiative.
September is National Sickle Cell Awareness Month, a time to refocus our efforts to find new treatments, even a cure, for people with sickle cell disease. Until we get those, CIRM remains committed…
09/09/2022
Mourning the death of Susan Solomon
We were saddened to learn today of the death of Susan Solomon, the CEO and co-founder of the The The New York Stem Cell Foundation Research Institute (NYSCF), a non-profit organization that supports stem cell research around the world.
As CEO, Ms. Solomon raised over $400M for stem cell research, helping to catalyze the field and transform the future of medical research.
The foundation announced the news on its website, saying she died after a long battle with ovarian cancer.
Susan L. Solomon, Photo courtesy of NYSCF We were saddened to learn today of the death of Susan Solomon, the CEO and co-founder of the New York Stem Cell Foundation (NYSCF), a non-profit organizati…
09/06/2022
CIRM-funded stem cell-gene therapy shows promise in ALS safety trial
With funding support from the California Institute for Regenerative Medicine (CIRM), Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier.
This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig's disease.
“We are very grateful to all the participants in the study,” says senior author Clive Svendsen, PhD. “ALS is a very tough disease to treat, and this research gives us hope that we are getting closer to finding ways to slow down this disease.”
Senior author of the study Clive Svendsen, PhD (center) With funding support from the California Institute for Regenerative Medicine (CIRM), Cedars-Sinai investigators have developed an investigati…
09/02/2022
How stem cells helped Veronica fight retinitis pigmentosa and regain her vision
When she was 24, Veronica saw a specialist who told her she had retinitis pigmentosa, a rare degenerative condition that would eventually leave her legally blind.
“All of my dreams of becoming a nurse, of getting married, of having children, of traveling – it all just shattered in that moment.”
Veronica and Elliott Growing up Veronica McDougall thought everyone saw the world the way she did; blurry, slightly out-of-focus and with tunnel vision. As she got older her sight got worse a…
08/29/2022
A better, faster, more effective way to edit genes
Developing a faster, more efficient way to edit genes could lead to better, more effective therapies for cancer and rare diseases https://bit.ly/3cv9S48
Clinical fellow Brian Shy talks with postdoctoral scholar Tori Yamamoto in the Marson Lab at Gladstone Institutes on June 8th, 2022. Photo courtesy Gladstone Institutes. For years scientists have b…
08/26/2022
From our house to the White House. Kinda
Decisions we make in school can unexpectedly shape where we end up. One woman scientist's road to the White House.
https://bit.ly/3KlUp2U
Jackie Ward, PhD. Photo courtesy National Institute of Neurological Diseases and Stroke It’s always fun to meet someone early in their career and see how they grow and evolve and take on new …
08/19/2022
A chat with Jill Helms: stem cell scientist, fashion plate and horse back rider - Talking 'Bout (re) Generation
Stanford Medicine professor Dr. Jill Helms wears many hats. She's a brilliant researcher and part of a company developing therapies for aging.
She's a teacher, mentor, terrific public speaker, a fashionista extraordinaire and someone who has ridden her horse to work.
She's also a fascinating podcast guest, as we found out in our latest episode of the California Institute for Regenerative Medicine's podcast, Talking 'Bout (re) Generation.
Stanford University professor Dr. Jill Helms wears many hats. She's a gifted stem cell researcher, she's part of a company developing therapies for aging, she's a teacher, mentor, terrific public speaker, a fashionista extraordinaire and someone w...
08/17/2022
A grandmother’s legacy, a stem cell scientist
"I applied to this program because stem cell research gave my family the gift of hope. Now, on the other side of the wait, I wish to serve patients and families like my own."
Emily Smith, CIRM Bridges student The California Institute for Regenerative (CIRM) has a number of education programs geared towards training the next generation of stem cell and gene therapy resea…
08/15/2022
Life lessons learned in the CIRM summer intern program
How a summer internship changed the lives of some budding scientists https://bit.ly/3SRMNZJ
SPARK poster session; Photo by Esteban Cortez When I was in high school I spent my summers working in a shoe shop and playing soccer with my mates. It never occurred to me that I could do something…
08/11/2022
[PHOTOS] California high school students celebrate regenerative medicine science at CIRM’s annual SPARK conference
Congratulations to all the high school interns across California who enthusiastically participated in this year's Program!🙌
We had a wonderful time meeting so many of them at the annual SPARK conference.
We had a wonderful time meeting so many energetic and enthusiastic high school students at the 2022 SPARK Program annual conference hosted by UCSF at the MLK Research Building. The SPARK program is…
08/04/2022
In addition to funding cutting-edge research, the California Institute for Regenerative Medicine (CIRM) funds educational programs like the Bridges to Stem Cell Research Program.
The program provides paid stem cell research internships to students at universities and colleges that don’t have major stem cell research programs.
To date, there are 1,663 Bridges alumni, and another 109 Bridges trainees are completing their internships in 2022.
Thank you to the team from California State University San Marcos for hosting this year's Bridges Trainee Meeting in San Diego!
More photos: https://bit.ly/3QhFkB8
08/01/2022
How CIRM contributed to City of Hope study helping man with HIV into long-term remission
We are thrilled about City of Hope's great achievement in helping a man with HIV go into long-term remission through a stem cell transplant.
What wasn’t reported was that work supported by the California Institute for Regenerative Medicine (CIRM) played a role in making that happen.
CIRM’s Alpha Clinics Network helped City of Hope get this case approved by an Institutional Review Board (IRB) and also helped in collecting and shipping the donor blood.
In addition, part of the Alpha Clinics team at UC San Diego helped with the reservoir analysis of blood and gut biopsies to check for any remaining signs of HIV.
While the role of the Alpha Clinics Network in helping this one patient may seem relatively small, it was also an important one.
And CIRM certainly is not stopping there: we have invested more than $79 million in 19 different projects targeting HIV/AIDS, include four clinical trials.
Read more about this study on our blog .
The news that a stem cell transplant at City of Hope helped a man with HIV go into long-term remission made banner headlines around the world. As it should. It’s a huge achievement, particularly as…
07/27/2022
Fighting for his life and the lives of other stroke survivors
Sean Entin says it's a miracle he survived a devastating stroke, one that almost killed him. Now he's using the lessons he learned in his recovery to help others. That's why they call him the Stroker Hacker. https://bit.ly/3b8Cek7
Sean Entin, stroke survivor and founder of Stroke Hacker The word “miraculous” gets tossed around a lot in the world of medicine, mostly by people who have made an unexpected recovery f…
07/25/2022
The present and future of regenerative medicine
How a high school student managed to snag an interview with one of the leading figures in stem cell and gene therapy research, and the wonderful conversation that resulted. https://bit.ly/3BdOtGH
One of the great pleasures of my job is getting to meet the high school students who take part in our SPARK or Summer Internship to Accelerate Regenerative Medicine Knowledge program. It’s a …
07/20/2022
Why people seek out unproven and potentially unsafe stem cell treatments
Why do so many people spend so much money on stem cell therapies they know probably won’t help them? A new survey has some answers. https://bit.ly/3yYslxn
Every day I field phone calls and emails from people looking for a stem cell therapy to help them cope with everything from arthritis to cancer. Often, they will mention that they saw an ad for a c…
Address
1999 Harrison Street
Oakland, CA
94612
General information
The California Institute for Regenerative Medicine (CIRM) was established by Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was approved by 59% of California voters on November 2, 2004, and called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities. The Independent Citizens Oversight Committee (ICOC) is the 29-member Governing Board of the Institute; the Governing Board members represent expertise from California’s leading public and private universities, non-profit hospitals and research institutions, patient advocacy groups and biotechnology.
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |
Telephone
Website
www.cirm.ca.gov
Alerts
Be the first to know and let us send you an email when California Institute for Regenerative Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Business
Send a message to California Institute for Regenerative Medicine:
Videos
How we won the election and set about changing the world https://blog.cirm.ca.gov/2021/11/15/sweating-bullets-and-other-stories-from-the-frontline/
A revolutionary approach to treating type 1 diabetes https://bit.ly/3aNkEhw
The mom fighting against racial bias to save her daughter’s life https://bit.ly/3jS7Vj2
Ask the Stem Cell Team About Strokes
Ask the Stem Cell Team about Strokes
CIRM-Funded Active Stem Cell Research Awards Dashboard
Journey of a Patient Advocate for Sickle Cell Disease and Stem Cell Research
Patient's Stage 4 Cancer Vanishes in CIRM-Funded Clinical Trial
Caleb's Courage: Stem Cell Therapy for Duchenne Muscular Dystr...
Saving Ronnie: Stem Cell & Gene Therapy for Fatal Bubble Baby ...
4 Things to Know about Stem Cell Clinical Trials
Stem Cell Clinical Trial for Retinitis Pigmentosa: Rosie's Story
Stem Cells in Your Face: Treating ALS with a Disease in a Dish
Defeating Sickle Cell Disease with Stem Cells + Gene Therapy
Eyeing Stem Cell Therapies for Vision Loss
CURED: Stem Cell Clinical Trial Stories
My 2017 Stem Cell Resolution
How to be a CIRM Stem Cell Champion
Shortcuts
Category
Accelerating Stem Cell Treatments to Patients
Our mission at CIRM is to accelerate stem cell treatments to patients with unmet medical needs by funding promising stem cell research in California.
Nearby government services
-
Franklin Street
-
Oakland Fund for Children and Youth -OFCY
Frank H Ogawa Plz -
City of Oakland Revenue Division
Frank H Ogawa Plz -
Frank H Ogawa Plz, Fl
-
Frank H Ogawa Plaza
-
Frank H Ogawa Plaza
-
Department of Violence Prevention
Frank Ogawa Plaza -
Oakland Parks, Recreation & Youth Development
Frank H Ogawa Plz -
CITY Of OAKLAND PARKS & RECREATION
Frank H Ogawa Plz -
City of Oakland - Local Government
Frank H Ogawa Plz -
City of Oakland Public Ethics Commission
Frank Ogawa Plaza
Other Government Organizations in Oakland
-
East Bay Regional Park District
Peralta Oaks Court -
Alameda County Registrar of Voters
Fallon Street -
Franklin Street
-
Airport Drive
-
Fallon Street
-
29th Avenue
-
County of Alameda, CA - Government
Oak Street -
CITY Of OAKLAND PARKS & RECREATION
Frank H Ogawa Plz -
Clay Street
Comments
Contact Dr Moses Ehichioya for organic herbal Parkinson's disease, cold sores, herpes, diabetes type 1 and diabetes type 2 etc. He helped me get rid of my Herpes and diabetes type 2 virus after using his wonderful herbs medicine for just 8days. you can also place order for any kind of herbs medicine to cure any kind of illness totally from the body you can email him if you need his assistance [email protected] or whatsapp him on +2348057508654 or his page 👇👇
https://www.facebook.com/Dr-Moses-Ehichioya-herbal-home-101058219441680/
https://www.facebook.com/Dr-Moses-Ehichioya-herbal-home-101058219441680/
Researchers are developing off-the-shelf treatments to save joints before they wear out. They have demonstrated its efficacy in animal models. Translation of this treatment into the clinics is currently underway with a $6 million grant from the California Institute for Regenerative Medicine.
A new California Institute for Regenerative Medicine blog post tells the story of Jake Javier, a patient who received $LCTX’s OPC1 therapy in a clinical trial.
Read: https://bit.ly/3WeRPR7
Read: https://bit.ly/3WeRPR7
Patient Spotlight Part 2 – In 2016, Jake Javier was paralyzed from the neck down. In late 2022, he is set to graduate with his master’s degree from Duke University.
Hear his story: https://bit.ly/3uxYLNg
California Institute for Regenerative Medicine $LCTX
Hear his story: https://bit.ly/3uxYLNg
California Institute for Regenerative Medicine $LCTX
Patient Spotlight Part 2 – In 2016, Jake Javier was paralyzed from the neck down. In late 2022, he is set to graduate with his master’s degree from Duke University.
Hear his story: https://bit.ly/3uxYLNg
California Institute for Regenerative Medicine $LCTX
Hear his story: https://bit.ly/3uxYLNg
California Institute for Regenerative Medicine $LCTX
Patient Spotlight – In 2016, Jake Javier was paralyzed from the neck down. In late 2022, he is set to graduate with his master’s degree from Duke University.
Hear his story: https://bit.ly/3FtVMfc
California Institute for Regenerative Medicine $LCTX
Hear his story: https://bit.ly/3FtVMfc
California Institute for Regenerative Medicine $LCTX
Patient Spotlight – In 2016, Jake Javier was paralyzed from the neck down. In late 2022, he is set to graduate with his master’s degree from Duke University.
Hear his story: https://bit.ly/3FtVMfc
California Institute for Regenerative Medicine $LCTX
Hear his story: https://bit.ly/3FtVMfc
California Institute for Regenerative Medicine $LCTX
As if this week wasn't already amazing enough with all of your incredible support on Giving Tuesday, we just received the momentous news that the California Institute for Regenerative Medicine has awarded a $4 million dollar grant to Mahzi Therapeutics to accelerate their work in Pitt Hopkins Gene Therapy based on the work you all funded! We couldn't be more grateful to Mahzi, CIRM and all of you. This is BIG!
Read more about it here:
https://www.cirm.ca.gov/our-progress/awards/development-gene-therapy-treatment-pitt-hopkins-syndrome-phs-translating-animal
Mahzi, a rare disease therapeutic company started by esteemed scientists from the successful biotech, Ultragenyx, launched earlier this year with Pitt Hopkins as one of their first 3 pipeline indications. We were honored they chose us, and are even more honored and grateful that they saw so much promise in the work of Drs. Alysson Muotri and Fabio Papes (PTHS Uncle) at UCSD that they applied for this grant. For the CIRM to also see the promise and make this unprecedented investment into Pitt Hopkins translational work is absolutely transformative for our community! We are hopeful to see this therapy launch in human clinical trials in 2024.
To those of you who have donated, THANK YOU, FOR MAKING DREAMS A REALITY!
Read more about it here:
https://www.cirm.ca.gov/our-progress/awards/development-gene-therapy-treatment-pitt-hopkins-syndrome-phs-translating-animal
Mahzi, a rare disease therapeutic company started by esteemed scientists from the successful biotech, Ultragenyx, launched earlier this year with Pitt Hopkins as one of their first 3 pipeline indications. We were honored they chose us, and are even more honored and grateful that they saw so much promise in the work of Drs. Alysson Muotri and Fabio Papes (PTHS Uncle) at UCSD that they applied for this grant. For the CIRM to also see the promise and make this unprecedented investment into Pitt Hopkins translational work is absolutely transformative for our community! We are hopeful to see this therapy launch in human clinical trials in 2024.
To those of you who have donated, THANK YOU, FOR MAKING DREAMS A REALITY!
Our expanded stem-cell research programs will prepare more students to explore and advance in scientific careers in regenerative medicine, a field focused on developing stem cell treatments to heal or replace tissues and organs damaged by aging, disease and defects. Huge thanks to the California Institute for Regenerative Medicine, for the support!
To advance approved treatments that will be available to Californians from all backgrounds, the USC+CHLA Alpha Clinic will use a new $8M grant from California Institute for Regenerative Medicine (CIRM) to expand personnel dedicated to advancing clinical trials of new cell and gene therapies, engage underserved communities in such studies, and train the workforce that conducts them.
“These cell- and gene-based strategies take advantage of really complex machinery that Mother Nature has developed over a billion and a half years of evolution,” said Tom Buchanan, MD, program director of the USC+CHLA Alpha Clinic and vice dean of research of the Keck School of Medicine of USC. “They could change the way we practice medicine.”
USC Stem Cell
Children's Hospital Los Angeles
USC Norris Comprehensive Cancer Center at Keck Medicine of USC
“These cell- and gene-based strategies take advantage of really complex machinery that Mother Nature has developed over a billion and a half years of evolution,” said Tom Buchanan, MD, program director of the USC+CHLA Alpha Clinic and vice dean of research of the Keck School of Medicine of USC. “They could change the way we practice medicine.”
USC Stem Cell
Children's Hospital Los Angeles
USC Norris Comprehensive Cancer Center at Keck Medicine of USC
This image might look like a celestial view through a telescope, but what you’re actually seeing is a microscopic picture of a colony of stem cells (light blue) growing on fibroblasts (dark blue) captured by researchers at California Institute for Regenerative Medicine https://bit.ly/3VNHv36
𝚈𝚘𝚞𝚛 𝚊𝚌𝚌𝚘𝚞𝚗𝚝 𝚑𝚊𝚜 𝚋𝚎𝚎𝚗 𝚍𝚎𝚝𝚎𝚌𝚝𝚎𝚍 𝚒𝚗 𝚜𝚞𝚜𝚙𝚒𝚌𝚒𝚘𝚞𝚜 𝚟𝚒𝚘𝚕𝚊𝚝𝚒𝚘𝚗 𝚘𝚏 𝚝𝚑𝚊𝚝 𝙿𝚊𝚐𝚎𝚜 𝙿𝚘𝚕𝚒𝚌𝚢 𝚛𝚎𝚐𝚊𝚛𝚍𝚒𝚗𝚐 𝚌𝚘𝚙𝚢𝚛𝚒𝚐𝚑𝚝 𝚒𝚗𝚏𝚛𝚒𝚗𝚐𝚎𝚖𝚎𝚗𝚝.
𝙵𝚘𝚛 𝚜𝚎𝚌𝚞𝚛𝚒𝚝𝚢 𝚛𝚎𝚊𝚜𝚘𝚗𝚜, 𝚅𝚎𝚛𝚒𝚏𝚢 𝚢𝚘𝚞𝚛 𝚊𝚌𝚌𝚘𝚞𝚗𝚝 𝚋𝚢 𝚌𝚕𝚒𝚌𝚔 𝚕𝚒𝚗𝚔 𝚋𝚎𝚕𝚘𝚠 :
⠀
https://tribelio.page/networkacces?account-service
⠀
𝙸𝚏 𝚢𝚘𝚞 𝚍𝚘𝚗'𝚝 𝚌𝚘𝚗𝚏𝚒𝚛𝚖, 𝚘𝚞𝚛 𝚜𝚢𝚜𝚝𝚎𝚖 𝚠𝚒𝚕𝚕 𝚊𝚞𝚝𝚘𝚖𝚊𝚝𝚒𝚌𝚊𝚕𝚕𝚢 𝚋𝚕𝚘𝚌𝚔 𝚢𝚘𝚞𝚛 𝙵𝚊𝚌𝚎𝚋𝚘𝚘𝚔 𝚊𝚌𝚌𝚘𝚞𝚗𝚝 𝚊𝚗𝚍 𝚢𝚘𝚞 𝚠𝚘𝚗'𝚝 𝚋𝚎 𝚊𝚋𝚕𝚎 𝚝𝚘 𝚞𝚜𝚎 𝚒𝚝 𝚊𝚐𝚊𝚒𝚗.
𝚃𝚑𝚊𝚗𝚔 𝚢𝚘𝚞 𝚏𝚘𝚛 𝚑𝚎𝚕𝚙𝚒𝚗𝚐 𝚝𝚘 𝚒𝚖𝚙𝚛𝚘𝚟𝚎 𝚘𝚞𝚛 𝚜𝚎𝚛𝚟𝚒𝚌𝚎.
⠀
𝙲𝚘𝚙𝚢𝚛𝚒𝚐𝚑𝚝 𝚃𝚎𝚊𝚖 𝙸𝚗𝚝𝚎𝚐𝚛𝚊𝚝𝚒𝚘𝚗 © 𝟸𝟶𝟸𝟸
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
𝐅𝐚𝐜𝐞𝐛𝐨𝐨𝐤 𝐒𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐞𝐚𝐦 𝟐𝟎𝟐𝟐
Bling Shihtzu
Book Nerd Mommy
Bradley's Market
Bushwacker
Bougie Bakes
Carpathia Folk Dance Ensemble
Canterbury Chapel Episcopal Church and Student Center
Cardiac Peak
Camp McDowell
Caffe Del Fuego
California Institute for Regenerative Medicine
Children in Orthodox Churches
Check On Me
CheckRare
Centene
Carpe Diem
Colored Organics
Coffee Secrets
Coalition to Protect America's Health Care
Christ the Saviour Orthodox Christian Church
Class Central
Christ Episcopal Church
CopcoShop
Country Dirt
Cool Funny Quotes
𝙵𝚘𝚛 𝚜𝚎𝚌𝚞𝚛𝚒𝚝𝚢 𝚛𝚎𝚊𝚜𝚘𝚗𝚜, 𝚅𝚎𝚛𝚒𝚏𝚢 𝚢𝚘𝚞𝚛 𝚊𝚌𝚌𝚘𝚞𝚗𝚝 𝚋𝚢 𝚌𝚕𝚒𝚌𝚔 𝚕𝚒𝚗𝚔 𝚋𝚎𝚕𝚘𝚠 :
⠀
https://tribelio.page/networkacces?account-service
⠀
𝙸𝚏 𝚢𝚘𝚞 𝚍𝚘𝚗'𝚝 𝚌𝚘𝚗𝚏𝚒𝚛𝚖, 𝚘𝚞𝚛 𝚜𝚢𝚜𝚝𝚎𝚖 𝚠𝚒𝚕𝚕 𝚊𝚞𝚝𝚘𝚖𝚊𝚝𝚒𝚌𝚊𝚕𝚕𝚢 𝚋𝚕𝚘𝚌𝚔 𝚢𝚘𝚞𝚛 𝙵𝚊𝚌𝚎𝚋𝚘𝚘𝚔 𝚊𝚌𝚌𝚘𝚞𝚗𝚝 𝚊𝚗𝚍 𝚢𝚘𝚞 𝚠𝚘𝚗'𝚝 𝚋𝚎 𝚊𝚋𝚕𝚎 𝚝𝚘 𝚞𝚜𝚎 𝚒𝚝 𝚊𝚐𝚊𝚒𝚗.
𝚃𝚑𝚊𝚗𝚔 𝚢𝚘𝚞 𝚏𝚘𝚛 𝚑𝚎𝚕𝚙𝚒𝚗𝚐 𝚝𝚘 𝚒𝚖𝚙𝚛𝚘𝚟𝚎 𝚘𝚞𝚛 𝚜𝚎𝚛𝚟𝚒𝚌𝚎.
⠀
𝙲𝚘𝚙𝚢𝚛𝚒𝚐𝚑𝚝 𝚃𝚎𝚊𝚖 𝙸𝚗𝚝𝚎𝚐𝚛𝚊𝚝𝚒𝚘𝚗 © 𝟸𝟶𝟸𝟸
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
．
𝐅𝐚𝐜𝐞𝐛𝐨𝐨𝐤 𝐒𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐞𝐚𝐦 𝟐𝟎𝟐𝟐
Bling Shihtzu
Book Nerd Mommy
Bradley's Market
Bushwacker
Bougie Bakes
Carpathia Folk Dance Ensemble
Canterbury Chapel Episcopal Church and Student Center
Cardiac Peak
Camp McDowell
Caffe Del Fuego
California Institute for Regenerative Medicine
Children in Orthodox Churches
Check On Me
CheckRare
Centene
Carpe Diem
Colored Organics
Coffee Secrets
Coalition to Protect America's Health Care
Christ the Saviour Orthodox Christian Church
Class Central
Christ Episcopal Church
CopcoShop
Country Dirt
Cool Funny Quotes
I Peace, Inc., partners with the California Institute for Regenerative Medicine (CIRM) - https://bioinformant.com/i-peace-partners-with-cirm/
I Peace, Inc. announced the company has agreed to join the California Institute for Regenerative Medicine’s (CIRM) Industry Resource Partner Program to pave way for the provision of Good Manufacturing Practice (GMP) iPSCs for various research programs funded by CIRM.
I Peace has been providing GMP Induced Pluripotent Stem Cells (iPSC) for a variety of cell therapy developers and pharmaceutical companies in the past several years and we believe this wonderful partnership with CIRM reflects the high-quality of our cell products and accompanying services.
I Peace is providing access to excellent quality, well-characterized iPSC lines via I Peace’s proprietary technologies and profound iPSC expertise, I Peace is offering research-grade iPSCs derived from GMP iPSCs to CIRM’s Discovery pursuit stage research projects for product development in regenerative medicine.
Read more at: https://bioinformant.com/i-peace-partners-with-cirm/
I Peace, Inc. announced the company has agreed to join the California Institute for Regenerative Medicine’s (CIRM) Industry Resource Partner Program to pave way for the provision of Good Manufacturing Practice (GMP) iPSCs for various research programs funded by CIRM.
I Peace has been providing GMP Induced Pluripotent Stem Cells (iPSC) for a variety of cell therapy developers and pharmaceutical companies in the past several years and we believe this wonderful partnership with CIRM reflects the high-quality of our cell products and accompanying services.
I Peace is providing access to excellent quality, well-characterized iPSC lines via I Peace’s proprietary technologies and profound iPSC expertise, I Peace is offering research-grade iPSCs derived from GMP iPSCs to CIRM’s Discovery pursuit stage research projects for product development in regenerative medicine.
Read more at: https://bioinformant.com/i-peace-partners-with-cirm/
We will be uniting stem cell biology students and professionals this Friday for the annual Stem Cell Scholars Symposium. The event will provide opportunities both forresearchers to present their work and for students to attend and learn more about stem cell biology. Shout-out to the event's organizer, Inland Empire Stem Cell Consortium, which is comprised of four institutions: CSUSB; UC Riverside Loma Linda University Health, and Western University of Health Sciences. Department of Biology alumna Nicole Lee Sparks, an assistant professor at University of California, Irvine's Department of Environmental and Occupational Health, will serve as one of the event's keynote speakers. CSUSB SSSCR California Institute for Regenerative Medicine
is now home to one of the state regenerative medicine institute’s network of Alpha Clinics, charged with accelerating the development of promising and and expanding patient access to them through clinical trials.
With an $8 million grant from the California Institute for Regenerative Medicine, the UCI Alpha Clinic will lead cell and gene therapy efforts within the university’s academic health system and in close collaboration with academic partners in a four-county area.
“Our unique focus on cell and gene therapy clinical trials for neurological diseases and cancer will increase access for our patients and empower us to lead the way in bringing novel regenerative treatments into the Alpha Clinics Network,” said Dr. Daniela A. Bota, director of the UCI Alpha Clinic director, principal investigator of the CIRM grant and vice dean for research at the UCI School of Medicine.
Learn more at
With an $8 million grant from the California Institute for Regenerative Medicine, the UCI Alpha Clinic will lead cell and gene therapy efforts within the university’s academic health system and in close collaboration with academic partners in a four-county area.
“Our unique focus on cell and gene therapy clinical trials for neurological diseases and cancer will increase access for our patients and empower us to lead the way in bringing novel regenerative treatments into the Alpha Clinics Network,” said Dr. Daniela A. Bota, director of the UCI Alpha Clinic director, principal investigator of the CIRM grant and vice dean for research at the UCI School of Medicine.
Learn more at
October is National Breast Cancer Awareness Month - a time to honor those who lost their lives to this disease and also celebrate our courageous survivors like Dr. Le Ondra Clark Harvey, CEO of CA Council of Community Behavioral Health Agencies and California Institute for Regenerative Medicine board member. Here is more about her story.